Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

298 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection.
Grefte A, van der Giessen M, van Son W, The TH. Grefte A, et al. J Infect Dis. 1993 Feb;167(2):270-7. doi: 10.1093/infdis/167.2.270. J Infect Dis. 1993. PMID: 8380609
Morphologically these cells closely resembled the classic cytomegalic inclusion cells, generally regarded as a diagnostic hallmark of CMV infection. ...The presence of CMV-infected endothelial cells in the peripheral blood of patients with an active CMV infec …
Morphologically these cells closely resembled the classic cytomegalic inclusion cells, generally regarded as a diagnostic hallmark of …
The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation.
Würsch AM, Gratama JW, Middeldorp JM, Nissen C, Gratwohl A, Speck B, Jansen J, D'Amaro J, The TH, De Gast GC. Würsch AM, et al. Clin Exp Immunol. 1985 Nov;62(2):278-87. Clin Exp Immunol. 1985. PMID: 3002684 Free PMC article.
Double-marker immunofluorescence revealed that the two markers were largely expressed by the same cells, which therefore had the T8+ HNK1+ phenotype. ...CMV infection did not influence the numbers of T4+ HNK1- and T8+ HNK1- T cells. The long-las …
Double-marker immunofluorescence revealed that the two markers were largely expressed by the same cells, which therefore had …
Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection.
Roenhorst HW, Middeldorp JM, Beelen JM, Schirm J, Tegzess AM, The TH. Roenhorst HW, et al. Clin Exp Immunol. 1985 Mar;59(3):709-15. Clin Exp Immunol. 1985. PMID: 2985307 Free PMC article.
In contrast the recipients (n = 7) who could maintain their CMV in latency after transplantation, had lower antibody titres and their in vitro memory lymphocyte responses against CMV-FF (median SI: 9.3) were comparable to those of the healthy controls (median SI: 11 …
In contrast the recipients (n = 7) who could maintain their CMV in latency after transplantation, had lower antibody titres and their …
The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity.
Gratama JW, Kardol M, Naipal AM, Slats J, Den Ouden A, Stijnen T, D'Amaro J, The TH, Bruning JW. Gratama JW, et al. Clin Exp Immunol. 1987 Jul;69(1):16-24. Clin Exp Immunol. 1987. PMID: 2820636 Free PMC article.
Two-colour immunofluorescence studies revealed that the HNK1+ cells coexpressing CD4 or high density CD8 were particularly increased in the number under the influence of CMV, but not the HNK1+ cells coexpressing CD16. ...That situation may reflect t
Two-colour immunofluorescence studies revealed that the HNK1+ cells coexpressing CD4 or high density CD8 were particularly increased …
Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients.
The TH, Andersen HK, Spencer ES, Klein G. The TH, et al. Clin Exp Immunol. 1977 Jun;28(3):502-5. Clin Exp Immunol. 1977. PMID: 196800 Free PMC article.
Five patients (forty sera) with CMV antibodies at the moment of renal implantation all showed CMV-EA antibody rises. Two patients remained seronegative until 4 years after transplantation. ...These results support the view that CMV-EA antibodies reflect an active vi …
Five patients (forty sera) with CMV antibodies at the moment of renal implantation all showed CMV-EA antibody rises. Two patients rem …
Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication.
Verschuuren EA, Stevens SJ, van Imhoff GW, Middeldorp JM, de Boer C, Koëter G, The TH, van Der Bij W. Verschuuren EA, et al. Transplantation. 2002 Jan 15;73(1):100-4. doi: 10.1097/00007890-200201150-00019. Transplantation. 2002. PMID: 11792987
EBV DNA was detectable in the blood samples of patients 2 and 3 before treatment with Rituximab and became negative instantly after Rituximab. ...CONCLUSIONS: Rituximab was effective for the treatment of PTLD without progression of transplant dysfunction in our pati …
EBV DNA was detectable in the blood samples of patients 2 and 3 before treatment with Rituximab and became negative instantly after R …
Donor-derived circulating endothelial cells after kidney transplantation.
Popa ER, Kas-Deelen AM, Hepkema BG, Van Son WJ, The TH, Harmsen MC. Popa ER, et al. Transplantation. 2002 Nov 15;74(9):1320-7. doi: 10.1097/00007890-200211150-00021. Transplantation. 2002. PMID: 12451273
BACKGROUND: In solid-organ transplantation, the allograft vasculature, in particular the endothelium, is prone to injury inflicted by peritransplantational and posttransplantational factors. ...Although less frequent (28.2%), recipient-type cEC were detected in t
BACKGROUND: In solid-organ transplantation, the allograft vasculature, in particular the endothelium, is prone to injury infli …
Kinetics of US28 gene expression during active human cytomegalovirus infection in lung-transplant recipients.
Boomker JM, Verschuuren EA, Brinker MG, de Leij LF, The TH, Harmsen MC. Boomker JM, et al. Among authors: the th. J Infect Dis. 2006 Jun 1;193(11):1552-6. doi: 10.1086/503779. Epub 2006 Apr 24. J Infect Dis. 2006. PMID: 16652284
The human cytomegalovirus-encoded receptor US28 increases the activity of the major immediate-early promoter/enhancer.
Boomker JM, The TH, de Leij LF, Harmsen MC. Boomker JM, et al. Among authors: the th. Virus Res. 2006 Jun;118(1-2):196-200. doi: 10.1016/j.virusres.2005.12.011. Epub 2006 Jan 31. Virus Res. 2006. PMID: 16448715
The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients.
Scheenstra R, Verschuuren EA, de Haan A, Slooff MJ, The TH, Bijleveld CM, Verkade HJ. Scheenstra R, et al. Among authors: the th. Transpl Infect Dis. 2004 Mar;6(1):15-22. doi: 10.1111/j.1399-3062.2004.00044.x. Transpl Infect Dis. 2004. PMID: 15225222
298 results
Jump to page
Feedback